Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1061 of 5804
-
Blood test strategy aims to cut TB treatment dropouts
Disease control Recruiting nowThis study is a two-arm, pragmatic, open-label, randomized clinical trial to determine the efficacy of Therapeutic Drug Monitoring (TDM) in preventing premature discontinuation of Linezolid (LZD) in participants with Rifampicin-resistant tuberculosis (RR-TB). Following the initia…
Phase: NA • Sponsor: Albert Einstein College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Experimental STAR-T cell therapy aims to tame multiple sclerosis
Disease control Not yet recruitingThis is a Phase I, single-arm, open-label, dose-escalation and dose-expansion study. The main objective is to explore the safety and tolerability of the universal STAR-T cell injection in patients with progressive or relapsing-remitting multiple sclerosis (MS).The secondary obje…
Phase: PHASE1 • Sponsor: Daishi Tian • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug cocktail targets Hard-to-Treat cancers with genetic flaw
Disease control Recruiting nowThe researchers are doing this study to test the safety of BMS-986504 in combination with standard disease-specific anticancer medication in people with metastatic/advanced unresectable MTAP-deleted solid tumor cancer.
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New insulin challenger: can GZR33 beat the standard for diabetes control?
Disease control Recruiting nowEvaluate the efficacy of GZR33 Injection and Insulin Degludec Injection (Tresiba®) in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Oral Antidiabetic Drugs.
Phase: PHASE3 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New cell therapy aims to slow vision loss in retinal disease
Disease control Recruiting nowThis is a first-in-human Phase 1 study evaluating the safety and tolerability of C.001 in patients with retinal diseases involving degeneration of the retinal pigment epithelium. Participants will receive a single administration of C.001 delivered by subretinal injection. The st…
Phase: PHASE1 • Sponsor: Cellio Therapeutics Inc • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New hope for advanced lung cancer: chemo-radiation combo enters trial
Disease control Not yet recruitingThis is a prospective, single-arm, investigator-initiated clinical study (IIT) designed to evaluate the efficacy and safety of nab-paclitaxel combined with local radiotherapy for patients with extensive-stage small cell lung cancer (ES-SCLC) whose disease has progressed after fir…
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can extra oxygen during surgery stop wound infections?
Disease control Recruiting nowOur specific aims are to investigate whether conservative (≤30%), intermediate (50%), or liberal (80%) inspired oxygen during and immediately after surgery: Aim 1: Reduces surgical site infections (SSIs or "wound infections") and other healthcare-associated infections (pneumonia …
Phase: PHASE4 • Sponsor: Monash University • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New combo therapy may shield diabetic kidneys from damage
Disease control OngoingProteinuria is an early marker of diabetic kidney disease and predicts progression to chronic kidney disease and cardiovascular complications. ARBs are proven to reduce proteinuria and slow renal damage, even in normotensive diabetic patients. SGLT2 inhibitors have recently shown…
Phase: PHASE2, PHASE3 • Sponsor: Dr Mudassar Saeed Pansota • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can a helpline prevent harmful sexual behavior in teens?
Prevention Not yet recruitingResearch suggests up to 77% of harmful sexual experiences during childhood are caused by other youth. Sometimes called peer-peer abuse or youth-perpetrated child sexual abuse, problematic and harmful sexual behavior among youth (PHSBY) involves sexual behaviors that are not devel…
Phase: NA • Sponsor: Center for Violence Prevention Research Inc • Aim: Prevention
Last updated Jun 27, 2026 12:06 UTC
-
New procedure aims to shrink kidney tumors without surgery
Disease control OngoingTo evaluate the efficacy and safety of selective endovascular embolization in the treatment of renal angiomyolipoma (AML). Materials and Methods: A prospective analysis will be conducted on patients who undergo transcatheter renal artery embolization for renal angiomyolipoma. Inc…
Sponsor: Botkin Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New drug cocktail aims to wipe out esophageal cancer before surgery
Disease control Not yet recruitingThis is a single-arm, exploratory clinical study.
Phase: PHASE2 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New daily pill aims to shed pounds in obesity trial
Disease control Recruiting nowThe primary objective of this study is to determine the efficacy of oral KAI-7535 once daily compared with placebo on percent change in body weight in participants living with obesity or overweight, with at least 1 weight-related comorbidity, without diabetes mellitus. Efficacy i…
Phase: PHASE2 • Sponsor: Kailera • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
VR home therapy could boost stroke arm recovery
Symptom relief Recruiting nowStroke rank second among the top causes of death, affecting millions of people in the worldwide. It has been reported that hemiplegia is the most common sequelae after stroke, accounting for about 50%-70% of all sequelae of the disease. About 75% of stroke patients are accompanie…
Phase: NA • Sponsor: Qilu Hospital of Shandong University • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Botox injection in throat may help sleep apnea sufferers
Disease control Not yet recruitingObstructive Sleep Apnea (OSA) is a sleep-related breathing disorder characterized by recurrent collapse of the upper airway during sleep, in which the palatopharyngeal muscle plays a key role in pathophysiology. Although continuous positive airway pressure (CPAP) remains the stan…
Phase: PHASE2 • Sponsor: Hospital Felicio Rocho • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Fewer needles, same safety? new study tests smarter prostate cancer detection.
Diagnosis Recruiting nowThe study aims to determine if a less painful and less invasive prostate biopsy approach is safe for certain men with a high risk of prostate cancer. Currently, when a man has a suspicious MRI scan, standard medical guidelines recommend a "combined biopsy." This means the urolog…
Phase: NA • Sponsor: Shanghai East Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 14:03 UTC
-
Brain infusion trial hopes to restore movement in chronic stroke patients
Disease control Recruiting nowThis study is for adults who have difficulty moving a few months after a stroke. In this study, ASP2246 will be given to people for the first time. This is known as a "first in human" study. The main aims of the study are to check the safety of ASP2246, how well people tolerate …
Phase: PHASE1, PHASE2 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Real-Time lung cancer detection: new imaging technique could speed up diagnosis
Diagnosis Recruiting nowThe goal of this observational study is to evaluate whether confocal laser endomicroscopy (CLE) can improve the real-time diagnosis of non-small cell lung cancer (NSCLC) in patients undergoing bronchoscopic biopsy for suspected lung tumors. The main questions it aims to answer ar…
Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jun 27, 2026 12:10 UTC
-
Could an arthritis drug curb alcohol cravings?
Disease control Recruiting nowPrimary: The primary objective of this study is to compare the efficacy of two different maintenance doses of apremilast (tablets) in reducing alcohol craving among subjects with moderate to severe alcohol use disorder (AUD) after two weeks of daily dosing. Secondary: Secondary …
Phase: PHASE2 • Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Gut bacteria cocktail aims to tame ulcerative colitis
Disease control Recruiting nowThe main goal of the study is to check if MH002 works and is safe to use. In a previous study in 45 patients with Ulcerative Colitis, MH002 was found to have favorable effects. In this study, 2 different doses will be tested, and long-term treatment effects will be investigated. …
Phase: PHASE2 • Sponsor: MRM Health NV • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Could extra ablation spots stop stubborn AFib?
Disease control Recruiting nowCatheter based ablation of atrial fibrillation (AF) is an established treatment modality for rhythm control of AF, with pulmonary vein isolation (PVI) being the cornerstone of this technique. While pulmonary vein triggers are the predominant arrhythmia mechanism in paroxysmal AF,…
Phase: NA • Sponsor: Edward Gerstenfeld, MD • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC